Veronika Borutinskaitė Selected Research

Histone Deacetylases (Histone Deacetylase)

1/2019

HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veronika Borutinskaitė Research Topics

Disease

4	Leukemia 01/2022 - 08/2015
4	Acute Promyelocytic Leukemia 01/2020 - 03/2017
3	Neoplasms (Cancer) 01/2022 - 08/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2019
1	Inflammation (Inflammations) 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2021

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2015
2	Histone Deacetylase InhibitorsIBA 01/2019 - 08/2015
2	Histones (Histone)IBA 01/2019 - 03/2017
2	belinostatIBA 01/2019 - 03/2017
2	3-deazaneplanocinIBA 01/2019 - 03/2017
1	S63845IBA 04/2021
1	Metformin (Glucophage)FDA LinkGeneric 04/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019
1	TransferasesIBA 01/2019
1	PolyphenolsIBA 01/2018
1	TeaIBA 01/2018
1	1,2,3,5,6,7- hexahydro- 7- methyl- 8- (4- tolylsulfinyl)- 5- indolizinoneIBA 03/2017
1	Antineoplastic Agents (Antineoplastics)IBA 08/2015
1	N1- (2- aminophenyl)- N8- phenyloctanediamideIBA 08/2015

Therapy/Procedure

5	Therapeutics 01/2022 - 08/2015
1	Immunomodulation 01/2022